BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27281989)

  • 1. The Functions of Effector Proteins in Yersinia Virulence.
    Zhang L; Mei M; Yu C; Shen W; Ma L; He J; Yi L
    Pol J Microbiol; 2016; 65(1):5-12. PubMed ID: 27281989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis.
    Viboud GI; Bliska JB
    Annu Rev Microbiol; 2005; 59():69-89. PubMed ID: 15847602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The virulence plasmid of Yersinia, an antihost genome.
    Cornelis GR; Boland A; Boyd AP; Geuijen C; Iriarte M; Neyt C; Sory MP; Stainier I
    Microbiol Mol Biol Rev; 1998 Dec; 62(4):1315-52. PubMed ID: 9841674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proinflammatory signalling stimulated by the type III translocation factor YopB is counteracted by multiple effectors in epithelial cells infected with Yersinia pseudotuberculosis.
    Viboud GI; So SS; Ryndak MB; Bliska JB
    Mol Microbiol; 2003 Mar; 47(5):1305-15. PubMed ID: 12603736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of Rho GTPases and the actin cytoskeleton by Yersinia outer proteins (Yops).
    Aepfelbacher M; Heesemann J
    Int J Med Microbiol; 2001 Sep; 291(4):269-76. PubMed ID: 11680787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Yersinia Ysc-Yop virulence apparatus.
    Cornelis GR
    Int J Med Microbiol; 2002 Feb; 291(6-7):455-62. PubMed ID: 11890544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular mechanisms of bacterial internalization counteracted by Yersinia.
    Fällman M; Gustavsson A
    Int Rev Cytol; 2005; 246():135-88. PubMed ID: 16164968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of Rho GTPases by type III secretion system translocated effectors of Yersinia.
    Aepfelbacher M
    Rev Physiol Biochem Pharmacol; 2004; 152():65-77. PubMed ID: 15378389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncovering an Important Role for YopJ in the Inhibition of Caspase-1 in Activated Macrophages and Promoting Yersinia pseudotuberculosis Virulence.
    Schoberle TJ; Chung LK; McPhee JB; Bogin B; Bliska JB
    Infect Immun; 2016 Apr; 84(4):1062-1072. PubMed ID: 26810037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspase-8 mediates caspase-1 processing and innate immune defense in response to bacterial blockade of NF-κB and MAPK signaling.
    Philip NH; Dillon CP; Snyder AG; Fitzgerald P; Wynosky-Dolfi MA; Zwack EE; Hu B; Fitzgerald L; Mauldin EA; Copenhaver AM; Shin S; Wei L; Parker M; Zhang J; Oberst A; Green DR; Brodsky IE
    Proc Natl Acad Sci U S A; 2014 May; 111(20):7385-90. PubMed ID: 24799700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of YopE and YopT activities in counteracting host signalling responses to Yersinia pseudotuberculosis infection.
    Viboud GI; Mejía E; Bliska JB
    Cell Microbiol; 2006 Sep; 8(9):1504-15. PubMed ID: 16922868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yersinia type III effectors perturb host innate immune responses.
    Pha K; Navarro L
    World J Biol Chem; 2016 Feb; 7(1):1-13. PubMed ID: 26981193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-kappa B activation.
    Zhou H; Monack DM; Kayagaki N; Wertz I; Yin J; Wolf B; Dixit VM
    J Exp Med; 2005 Nov; 202(10):1327-32. PubMed ID: 16301742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The type III secretion chaperone LcrH co-operates with YopD to establish a negative, regulatory loop for control of Yop synthesis in Yersinia pseudotuberculosis.
    Francis MS; Lloyd SA; Wolf-Watz H
    Mol Microbiol; 2001 Nov; 42(4):1075-93. PubMed ID: 11737648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of chaperone-dependent Yop secretion/translocation and effector function using a mini-virulence plasmid of Yersinia enterocolitica.
    Trülzsch K; Roggenkamp A; Aepfelbacher M; Wilharm G; Ruckdeschel K; Heesemann J
    Int J Med Microbiol; 2003 Jun; 293(2-3):167-77. PubMed ID: 12868653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YopT, a new Yersinia Yop effector protein, affects the cytoskeleton of host cells.
    Iriarte M; Cornelis GR
    Mol Microbiol; 1998 Aug; 29(3):915-29. PubMed ID: 9723929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and cell biology aspects of plague.
    Cornelis GR
    Proc Natl Acad Sci U S A; 2000 Aug; 97(16):8778-83. PubMed ID: 10922034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yersinia protein kinase YopO is activated by a novel G-actin binding process.
    Trasak C; Zenner G; Vogel A; Yüksekdag G; Rost R; Haase I; Fischer M; Israel L; Imhof A; Linder S; Schleicher M; Aepfelbacher M
    J Biol Chem; 2007 Jan; 282(4):2268-77. PubMed ID: 17121817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of YopP in suppression of tumor necrosis factor alpha release by macrophages during Yersinia infection.
    Boland A; Cornelis GR
    Infect Immun; 1998 May; 66(5):1878-84. PubMed ID: 9573064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heightened Virulence of
    Mares CA; Lugo FP; Albataineh M; Goins BA; Newton IG; Isberg RR; Bergman MA
    Infect Immun; 2021 Nov; 89(12):e0043021. PubMed ID: 34543120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.